Adoptive transfer of HDVax-induced LILRB4+SEMA4a− or LILRB4+SEMA4a+ mItgb1-specific CD4+ T cells comparably ablated T3 tumour rejection in the Rag2−/− ACT assay (Fig. 3f). The gene discussed is SEMA4A; the disease is neoplasm.